Deutsche Bank Ag\ Scopus Bio Pharma Inc. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
About Scopus BioPharma Inc.
- Ticker SCPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,094,300
- Description
- Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...